These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 25610880)

  • 1. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
    Lee YS; Lee EK; Oh HH; Choi CS; Kim S; Jun HS
    J Diabetes Res; 2014; 2014():961732. PubMed ID: 25610880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evodia alkaloids suppress gluconeogenesis and lipogenesis by activating the constitutive androstane receptor.
    Yu L; Wang Z; Huang M; Li Y; Zeng K; Lei J; Hu H; Chen B; Lu J; Xie W; Zeng S
    Biochim Biophys Acta; 2016 Sep; 1859(9):1100-1111. PubMed ID: 26455953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium arsenite induces orphan nuclear receptor SHP gene expression via AMP-activated protein kinase to inhibit gluconeogenic enzyme gene expression.
    Chanda D; Kim SJ; Lee IK; Shong M; Choi HS
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E368-79. PubMed ID: 18505831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice.
    Tanaka H; Nagashima T; Shimaya A; Urano Y; Shimokawa T; Shibasaki M
    Eur J Pharmacol; 2010 Oct; 645(1-3):185-91. PubMed ID: 20655898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
    De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
    J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic NPC1L1 overexpression ameliorates glucose metabolism in diabetic mice via suppression of gluconeogenesis.
    Kurano M; Hara M; Satoh H; Tsukamoto K
    Metabolism; 2015 May; 64(5):588-96. PubMed ID: 25660144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
    Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
    Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.
    Wei S; Zhang M; Yu Y; Lan X; Yao F; Yan X; Chen L; Hatch GM
    PLoS One; 2016; 11(3):e0152097. PubMed ID: 27011261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel FoxO1 inhibitor, JY-2, ameliorates palmitic acid-induced lipotoxicity and gluconeogenesis in a murine model.
    Choi HE; Kim Y; Lee HJ; Cheon HG
    Eur J Pharmacol; 2021 May; 899():174011. PubMed ID: 33705803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red Pepper (
    Kim HK; Jeong J; Kang EY; Go GW
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32842462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Phloroglucinol, A Component of Ecklonia cava Extract, on Hepatic Glucose Production.
    Yoon JY; Choi H; Jun HS
    Mar Drugs; 2017 Apr; 15(4):. PubMed ID: 28379184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
    Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
    J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner.
    Lee JM; Seo WY; Song KH; Chanda D; Kim YD; Kim DK; Lee MW; Ryu D; Kim YH; Noh JR; Lee CH; Chiang JY; Koo SH; Choi HS
    J Biol Chem; 2010 Oct; 285(42):32182-91. PubMed ID: 20688914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The constitutive androstane receptor activator 4-[(4R,6R)-4,6-diphenyl-1,3-dioxan-2-yl]-N,N-dimethylaniline inhibits the gluconeogenic genes PEPCK and G6Pase through the suppression of HNF4α and FOXO1 transcriptional activity.
    Yarushkin AA; Kachaylo EM; Pustylnyak VO
    Br J Pharmacol; 2013 Apr; 168(8):1923-32. PubMed ID: 23231652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feedback regulation of hepatic gluconeogenesis through modulation of SHP/Nr0b2 gene expression by Sirt1 and FoxO1.
    Wei D; Tao R; Zhang Y; White MF; Dong XC
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E312-20. PubMed ID: 21081708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis.
    Zhang M; Lv X; Li J; Meng Z; Wang Q; Chang W; Li W; Chen L; Liu Y
    Mol Cell Endocrinol; 2012 Nov; 363(1-2):122-30. PubMed ID: 22922125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
    Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
    Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice.
    Nagashima T; Shigematsu N; Maruki R; Urano Y; Tanaka H; Shimaya A; Shimokawa T; Shibasaki M
    Mol Pharmacol; 2010 Nov; 78(5):961-70. PubMed ID: 20736318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bradykinin inhibits hepatic gluconeogenesis in obese mice.
    Barros CC; Haro A; Russo FJ; Schadock I; Almeida SS; Reis FC; Moraes MR; Haidar A; Hirata AE; Mori M; Bacurau RF; Würtele M; Bader M; Pesquero JB; Araujo RC
    Lab Invest; 2012 Oct; 92(10):1419-27. PubMed ID: 22868909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.